This company has been marked as potentially delisted and may not be actively trading. Zafgen (ZFGN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock ZFGN vs. ETHZ, SBTX, AVTE, NLTX, BIOA, VIRI, WHWK, LITS, SPRB, and ELYMShould you be buying Zafgen stock or one of its competitors? The main competitors of Zafgen include Flag Ship Acquisition (ETHZ), Silverback Therapeutics (SBTX), Aerovate Therapeutics (AVTE), Neoleukin Therapeutics (NLTX), BioAge Labs (BIOA), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), Lite Strategy (LITS), Spruce Biosciences (SPRB), and Eliem Therapeutics (ELYM). Zafgen vs. Its Competitors Flag Ship Acquisition Silverback Therapeutics Aerovate Therapeutics Neoleukin Therapeutics BioAge Labs Virios Therapeutics Whitehawk Therapeutics Lite Strategy Spruce Biosciences Eliem Therapeutics Zafgen (NASDAQ:ZFGN) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. Do analysts recommend ZFGN or ETHZ? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zafgen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders & institutionals hold more shares of ZFGN or ETHZ? 70.4% of Zafgen shares are owned by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are owned by institutional investors. 14.2% of Zafgen shares are owned by company insiders. Comparatively, 5.4% of Flag Ship Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is ZFGN or ETHZ more profitable? Zafgen's return on equity of -51.34% beat Flag Ship Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets ZafgenN/A -51.34% -34.55% Flag Ship Acquisition N/A -141.25%-80.77% Does the media prefer ZFGN or ETHZ? In the previous week, Flag Ship Acquisition had 6 more articles in the media than Zafgen. MarketBeat recorded 6 mentions for Flag Ship Acquisition and 0 mentions for Zafgen. Flag Ship Acquisition's average media sentiment score of 0.52 beat Zafgen's score of 0.00 indicating that Flag Ship Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Zafgen Neutral Flag Ship Acquisition Positive Which has higher earnings & valuation, ZFGN or ETHZ? Zafgen is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZafgenN/AN/A-$45.41M-$1.07-3.97Flag Ship AcquisitionN/AN/A-$6.17M-$15.07-0.13 Which has more risk and volatility, ZFGN or ETHZ? Zafgen has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Comparatively, Flag Ship Acquisition has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. SummaryFlag Ship Acquisition beats Zafgen on 6 of the 11 factors compared between the two stocks. Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZFGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZFGN vs. The Competition Export to ExcelMetricZafgenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$159.25M$787.62M$6.05B$10.30BDividend YieldN/A4.84%5.73%4.82%P/E Ratio-4.431.2885.3127.10Price / SalesN/A29.85601.46133.24Price / CashN/A17.6425.7730.18Price / Book3.157.5412.676.69Net Income-$45.41M-$7.59M$3.32B$276.55M Zafgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZFGNZafgenN/A$4.25-2.5%N/A-37.6%$159.25MN/A-4.4338High Trading VolumeETHZFlag Ship AcquisitionN/A$2.33-8.6%N/AN/A$419.30MN/A-0.157SBTXSilverback TherapeuticsN/A$10.27-0.4%N/A-22.0%$370.32MN/A-4.2483High Trading VolumeAVTEAerovate TherapeuticsN/A$9.14+3.2%N/A-87.8%$264.92MN/A-3.0620High Trading VolumeNLTXNeoleukin TherapeuticsN/A$23.09+3.4%N/A-38.9%$217MN/A-7.4290High Trading VolumeBIOABioAge Labs0.182 of 5 stars$5.60-0.5%N/AN/A$201.84MN/A0.00N/AVIRIVirios TherapeuticsN/A$6.69+4.4%$5.00-25.3%+30.3%$128.84MN/A-24.785Gap DownWHWKWhitehawk Therapeutics0.9943 of 5 stars$2.22+3.3%N/AN/A$101.33M$25.98M-37.0021LITSLite StrategyN/A$2.45-5.8%N/AN/A$92.70M$65.30M0.00100News CoverageGap DownSPRBSpruce Biosciences0.6543 of 5 stars$182.60+40.0%$131.25-28.1%+377.2%$73.24M$4.91M-2.1220Gap UpELYMEliem TherapeuticsN/A$1.81-8.6%N/A-66.8%$53.85MN/A-3.429 Related Companies and Tools Related Companies ETHZ Alternatives SBTX Alternatives AVTE Alternatives NLTX Alternatives BIOA Alternatives VIRI Alternatives WHWK Alternatives LITS Alternatives SPRB Alternatives ELYM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZFGN) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zafgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
